Figure 7: PhenDC3 activates GAr-limited antigen presentation. | Nature Communications

Figure 7: PhenDC3 activates GAr-limited antigen presentation.

From: Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

Figure 7

(a) PhenDC3 increases T-cell proliferation. Same experiment as in Fig. 3c,d except that 235GAr-OVA (upper panels) and OVA (lower panels) expressing H1299 cells were treated with 5 μM PhenDC3 or, as control, with DMSO as indicated. Quantifications of proliferating T lymphocytes following PhenDC3 treatment as compared to DMSO-treated cells are shown in the graphs on the right. The results were compared using the Student’s t-test (**P<0.01; NS: not significant). (b) SDS-PAGE and western blot analysis of cells used in a.

Back to article page